改良肌酐指数评估的瘦体重轨迹与血液透析患者死亡率
本研究为回顾性队列研究,纳入349例维持性血液透析门诊患者,评估1年内改良肌酐指数(瘦体重替代指标)与BMI轨迹和全因死亡率的关联。结果显示,改良肌酐指数下降和BMI下降均独立与全因死亡风险升高相关,且改良肌酐指数下降较BMI下降提供额外预后信息。
要点
- 改良肌酐指数下降与血液透析患者全因死亡风险升高独立相关。
- 改良肌酐指数轨迹可提供BMI轨迹之外的额外预后信息。
- 同时出现改良肌酐指数和BMI下降的患者死亡风险最高。
核心结论
- 改良肌酐指数轨迹独立与血液透析患者全因死亡率相关,并提供BMI轨迹之外的额外预后信息。
研究设计与样本
- 回顾性队列研究,纳入349例每周3次维持性血液透析门诊患者,平均年龄67.4岁,60%为男性。
主要发现
- 中位随访1157天期间,79例患者死亡。
- 改良肌酐指数每下降1个标准差,全因死亡风险HR为1.31(95%CI 1.11-1.54)。
- BMI每下降1个标准差,全因死亡风险HR为1.25(95%CI 1.01-1.54)。
- 与改良肌酐指数无下降/BMI下降组相比,改良肌酐指数下降/BMI无下降组HR为2.14(95%CI 1.04-4.45)。
- 与改良肌酐指数无下降/BMI下降组相比,改良肌酐指数下降/BMI下降组HR为3.05(95%CI 1.58-5.90)。
临床怎么用
- 在血液透析患者中可动态监测改良肌酐指数轨迹,辅助评估瘦体重变化及死亡风险。
局限性
- 缺乏瘦体重和脂肪量的直接测量。
- 结果对非日本血液透析人群的普遍性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Although a declining body mass index (BMI) is associated with higher mortality in patients on hemodialysis, BMI cannot distinguish lean body mass from fat mass. It remains unclear whether changes over time in lean body mass are associated with mortality. We examined the prognostic significance of changes in the modified creatinine index, a proxy for lean body mass. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: Outpatients (n=349; mean age, 67.4 years; 60% men) undergoing maintenance hemodialysis 3 times a week at a treatment center. PREDICTOR: Modified creatinine index and BMI trajectories over a 1-year period. OUTCOMES: All-cause mortality. ANALYTICAL APPROACH: We calculated the percentage of change in modified creatinine index and BMI over a 1-year period. Patients were categorized according to change in modified creatinine index/BMI: no decline (≥0%) or decline (<0%). Kaplan-Meier and Cox proportional hazard analyses were performed to examine whether modified creatinine index and BMI trajectories were associated with mortality. RESULTS: During follow-up (median, 1,157 days), 79 patients died. Decreasing modified creatinine index (HR, 1.31; 95% CI, 1.11-1.54) and BMI (HR, 1.25; 95% CI, 1.01-1.54) over time, measured as continuous variables and expressed per 1-standard deviation decrease, were independently associated with higher risk for all-cause mortality. The decline in modified creatinine index/no decline in BMI group (HR, 2.14; 95% CI, 1.04-4.45) and the decline in modified creatinine index/decline in BMI group (HR, 3.05; 95% CI, 1.58-5.90) had higher rates of mortality compared to the no decline in modified creatinine index/decline in BMI group. LIMITATIONS: The absence of a direct measure of lean body and fat mass and limited generalizability to non-Japanese hemodialysis populations. CONCLUSIONS: The modified creatinine index trajectory is independently associated with mortality and provides additional prognostic information to the BMI trajectory in patients on hemodialysis.
引用
- Suzuki Y, Matsuzawa R, Kamiya K, et al. Trajectory of Lean Body Mass Assessed Using the Modified Creatinine Index and Mortality in Hemodialysis Patients. Am J Kidney Dis. 2019. PMID: 31563467. doi:10.1053/j.ajkd.2019.05.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。